Conference News

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

Featured

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

Repeat injections of the angiotensinogen-targeted drug didn’t reduce BP more than a single dose.

By Caitlin E. Cox

March 28, 2026

Latest Conference News

See All

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

By L.A. McKeown

April 02, 2026
Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

By Caitlin E. Cox

April 02, 2026
Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

By Todd Neale

April 02, 2026
Olezarsen Doesn’t Lower Plaque Volume: Essence-TIMI 73b

By Yael L. Maxwell

April 01, 2026
Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

By Michael O'Riordan

April 01, 2026
Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

By Todd Neale

April 01, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.